Bayer’s CONFIDENCE Study Shows Kerendia and Empagliflozin Reduce UACR in T2D-CKD
German pharmaceutical giant Bayer AG (ETR: BAYN) announced results from the Phase II CONFIDENCE study,...
Lifetech Scientific Plans RMB 150 Million Investment in AffectOR MedTech
China-based Lifetech Scientific Corporation (HKG: 1302) announced plans to invest RMB 150 million (USD 21...
OBI Pharma Partners with TegMine to Develop Antibody-Drug Conjugates
Taiwan-based OBI Pharma announced a collaboration with San Francisco-based TegMine Therapeutics, Inc. to develop antibody-drug...
NeoCura Bio-Medical Gains NMPA Approval for mRNA Cancer Vaccine Trial
China-based NeoCura Bio-Medical Technology Co., Ltd. announced that it has received approval from the National...
YolTech Receives FDA Clearance for PCSK9-Targeted Base Editing Drug YOLT-101
Shanghai-based YolTech Therapeutics announced that it has received clearance from the US Food and Drug...
Kindstar Global Partners with Biostate AI to Advance Precision Medicine
China-based Kindstar Global (HKG: 9960) announced the establishment of a joint venture (JV) with US-headquartered...
Genesis MedTech Wins NMPA Approval for Locally Developed Thrombus Aspiration Catheter
Singapore-based Genesis MedTech announced that it has received marketing approval from China’s National Medical Products...
Zelgen Bio Collaborates with Merck KGaA for rhTSH Promotion in China
China’s Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced a collaboration agreement with Merck KGaA...
HELP Therapeutics’ iPSC-Derived Cardiomyocyte Therapy Enters US Clinical Trials
Nanjing-based HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that its innovative induced...
Lancet Robotics Secures Series A+ Funding for Surgical Robot Development
Shenzhen-based Lancet Robotics, a developer of orthopedic joint replacement surgical robots, has reportedly secured “tens...
Biocytogen’s RenMab Platform Wins Japanese Patent, Expanding IP Portfolio
China’s Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) announced that its RenMab platform, a key...
Bayer’s Vividion Gains Global Rights to WRN Inhibitor VVD-214
German pharmaceutical giant Bayer AG (ETR: BAYN) announced that its wholly owned subsidiary Vividion Therapeutics,...
Nanjing Leads Biolabs Files for Hong Kong IPO Amid Product Pipeline Progress
China-based Nanjing Leads Biolabs Co., Ltd., a clinical-stage biotech company focusing on oncology and autoimmune...
Acotec Scientific Gains NMPA Approval for AcoArt Verbena Vertebral Balloon
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has received marketing approval from China’s National Medical...
Hengrui Pharmaceuticals Gains NMPA Approval for Phase Ib/II Study of SHR-A1811, Adebrelimab and Famitinib in Solid Tumors
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received approval from...
Qure Biotechnology Secures RMB 100 Million Series C1 Financing
China-based Qure Biotechnology (Shanghai) Co., Ltd. announced the completion of a Series C1 financing round...
Lianhuan Pharma Gains NMPA Approval for No-Spa Generic
China-based Jiangsu Lianhuan Pharmaceutical Co., Ltd (SHA: 600513) announced that it has received market clearance...
Roche’s Evrysdi 5mg Tablet Gains EU Commission Approval for Spinal Muscular Atrophy
Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced that the European Commission (EC) has...
Shanghai OPM Biosciences Plans Acqusition of PharmaLegacy Labs for RMB 1.45 Billion
Shanghai OPM Biosciences Co., Ltd (SHA: 688293), a China-based cell culture-focused Contract Development and Manufacturing...
Sunshine Guojian’s SSGJ-613 Meets Phase III Endpoints in Acute Gouty Arthritis
China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), announced...